Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 6Recruiting 4Completed 2Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Tissue Adhesions 1Neoplasms 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Minimally Invasive Surgical Procedures × Clear all
NCT05999162 2023-08-21

Mechanical Ileus in the Era of Minimally Invasive Colorectal Surgery

National Taiwan University Hospital

Completed
1,544 enrolled
Gastrointestinal

Tissue Adhesions, Colorectal Neoplasms

NCT02463877 2022-09-14

A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy

University of California, San Diego

Phase 2 Completed
18 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡